Clinical Trials Directory

Trials / Unknown

UnknownNCT02698644

Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
40 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Is to assess the effectiveness of hysteroscopic tubal application of Iso Amyl-2-cyanoacrylate in occluding uterine tubes of women, which would make it an easy approach for occluding tubes with hydrosalpinx prior to IVF and in tubal sterilization.

Detailed description

The study will be conducted according to the guidelines on human experimentation of the 1975 Declaration of Helsinki. For all patients after taking signed informed consent , transcervical hysteroscopic cannulation of the proximal one centimeter of both fallopian tubes, will be done using a 5 Fr, 42cm long, polyethylene ureteric catheter, where 0.5 ml of Iso Amyl-2-cyanoacrylate (AMCRYLATE®) will be injected in each side. All the surgical procedures will be performed without anesthesia, only premedication with an NSAID (e.g. NaproxenR) is given orally one hour before the procedure. Each patient will be under close observation for the first 24 hours postprocedure for any signs of inflammation as abdominal pain, tenderness or fever and for the vital data. Total abdominal hysterectomy and bilateral salpingoophorectomy will be done, second day, a week, two weeks and three weeks and four weeks after injection,. Hysterectomy samples will be sent to histopathologist to assess the degree of tubal occlusion and the extent and the severity of inflammation in the tubal wall.

Conditions

Interventions

TypeNameDescription
DRUGIsoamyl-2-cyanoacrylateIsoamyl-2-cyanoacrylate will be injected inside fallopian tube hysteroscopically through ureteric catheter

Timeline

Start date
2016-01-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2016-03-04
Last updated
2016-03-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02698644. Inclusion in this directory is not an endorsement.

Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate (NCT02698644) · Clinical Trials Directory